Partner Content Partner Content Chairs from Aerie Pharmaceuticals & Santen Inc Invitation to... Ophthalmic Drugs Conference Invitation
Partner Content Partner Content Registration opens for SMi’s 4th Annual Ophthalmic Drugs Con... Registration opens for Ophthalmic Drugs Conference
Partner Content Partner Content Speaker Interview with iVeena Released for 3rd Ophthalmic Dr... Ophthalmic Drugs Conference Speaker Interview
Partner Content Partner Content Explore the future of ocular gene editing and strategic drug... Ophthalmic Drugs Conference
News Novo rapped by FDA for not reporting drug adverse effects Novo Nordisk has been sent a warning letter from the FDA for violations of postmarketing adverse drug experience (PADE) regulations.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
